Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$94.45
Market cap
$9.52B
P/E Ratio
22.49
Dividend/share
$0.62
EPS
$4.2
Enterprise value
$12.12B
Encompass Health Corporation , based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states
Highlights
The company's equity rose by 26% YoY and by 7% QoQ
Encompass Health's net income has increased by 20% YoY and by 7% from the previous quarter
Encompass Health's quick ratio has decreased by 23% QoQ and by 19% YoY
The P/E is 9% above the 5-year quarterly average of 20.6 and 5% above the last 4 quarters average of 21.4
Key stats
What are the main financial stats of EHC
Market
Valuations
Earnings
Shares outstanding
100.75M
Market cap
$9.52B
Enterprise value
$12.12B
Price to earnings (P/E)
22.49
Price to book (P/B)
4.85
Price to sales (P/S)
1.81
EV/EBIT
14.41
EV/EBITDA
10.7
EV/Sales
2.32
Revenue
$5.22B
Gross profit
$1.32B
Net income
$551.5M
EBIT
$840.6M
EBITDA
$1.13B
Free cash flow
$258.6M
Per share
Balance sheet
Liquidity
EPS
$4.2
EPS diluted
$4.13
Free cash flow per share
$2.59
Book value per share
$19.48
Revenue per share
$52.2
TBVPS
$48.83
Total assets
$6.46B
Total liabilities
$3.73B
Debt
$2.8B
Equity
$1.96B
Working capital
$36.5M
Debt to equity
1.43
Current ratio
1.04
Quick ratio
0.86
Net debt/EBITDA
2.3
Margins
Efficiency
Dividend
EBITDA margin
21.7%
Gross margin
25.3%
Net margin
10.6%
Operating margin
15.8%
Return on assets
8.8%
Return on equity
30.7%
Return on invested capital
12.5%
Return on capital employed
15.1%
Return on sales
16.1%
Dividend yield
0.66%
DPS
$0.62
Payout ratio
14.8%
EHC stock price
How has the Encompass Health stock price performed over time
Intraday
0.66%
1 week
-3.81%
1 month
-4.53%
1 year
43.52%
YTD
41.56%
QTD
-2.27%
Financial performance
How have Encompass Health's revenue and profit performed over time
Revenue
$5.22B
Gross profit
$1.32B
Operating income
$822.1M
Net income
$551.5M
Gross margin
25.3%
Net margin
10.6%
Encompass Health's net income has increased by 20% YoY and by 7% from the previous quarter
Encompass Health's operating income has increased by 14% YoY and by 3.7% from the previous quarter
EHC's gross profit is up by 12% YoY and by 3.5% from the previous quarter
Encompass Health's revenue has increased by 11% YoY and by 2.8% QoQ
Growth
What is Encompass Health's growth rate over time
Valuation
What is Encompass Health stock price valuation
P/E
22.49
P/B
4.85
P/S
1.81
EV/EBIT
14.41
EV/EBITDA
10.7
EV/Sales
2.32
Encompass Health's EPS has increased by 19% YoY and by 6% from the previous quarter
The P/E is 9% above the 5-year quarterly average of 20.6 and 5% above the last 4 quarters average of 21.4
The company's equity rose by 26% YoY and by 7% QoQ
EHC's price to book (P/B) is 13% higher than its 5-year quarterly average of 4.3 and 5% higher than its last 4 quarters average of 4.6
EHC's P/S is 13% above its 5-year quarterly average of 1.6 and 13% above its last 4 quarters average of 1.6
Encompass Health's revenue has increased by 11% YoY and by 2.8% QoQ
Efficiency
How efficient is Encompass Health business performance
The ROIC has grown by 11% YoY and by 5% from the previous quarter
Encompass Health's return on assets has increased by 10% YoY and by 4.8% QoQ
Encompass Health's ROE has decreased by 4.7% YoY
Encompass Health's ROS has increased by 2.5% YoY
Dividends
What is EHC's dividend history
DPS
$0.62
Dividend yield
0.66%
Payout ratio
14.8%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Encompass Health financials performed over time
The total assets is 73% greater than the total liabilities
EHC's current ratio is down by 23% since the previous quarter and by 18% year-on-year
Encompass Health's quick ratio has decreased by 23% QoQ and by 19% YoY
The debt is 43% more than the equity
The company's equity rose by 26% YoY and by 7% QoQ
Encompass Health's debt to equity has decreased by 24% YoY and by 11% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.